Investor

OrbiMed Israel

Last cheque observed Oct 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund, Dec 2015Private equity

Series ASeries C

Cheques on record
0%of best year0cheques in 12 months, 4 on record
Since the last cheque2923days00hrs00min00sec
Median round$46MRounds led0 of 4
Pitch OrbiMed Israel

OrbiMed Israel highlights

  1. 01

    4 rounds on record

  2. 02

    Mostly Series A and Series C: 100% of its rounds

What they do

Type
Private equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first4 appearances

  1. 2018

    2 rounds

  2. Oct
    GalectoSeries C · DK · FinSMEs$90MWith 9 others
  3. Oct
    89BioSeries A · US · FinSMEs$60MWith 3 others
  4. 2017

    2 rounds

  5. Dec
    ChemomAbIL · FinSMEs$10MWith 2 others
  6. Jun
    Tisbury PharmaceuticalsSeries A · US · FinSMEs$32MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration7 named

ANAnat NaschitzExecutive OfficeriFiling they signed
CLCarl L. GordonExecutive OfficeriFiling they signed
ECErez ChimovitsExecutive OfficeriFiling they signed
JTJonathan T. SilversteinExecutive OfficeriFiling they signed
NDNissim DarvishExecutive OfficeriFiling they signed
SDSamuel D. IsalyPromoteriFiling they signed
WCW. Carter NeildPromoteriFiling they signed

We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as OrbiMed Israel. A count of rooms they were both in, not a relationship either has claimed.

OrbiMedPrivate equity2rounds together

Recently backed

The latest companies OrbiMed Israel put money into.

Galecto$90M · Oct 201889Bio$60M · Oct 2018

Quick answers about OrbiMed Israel

What does OrbiMed Israel invest in?

OrbiMed Israel invests most often at Series A and Series C (100% of the rounds on record).

How active is OrbiMed Israel?

4 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2018.

What has OrbiMed Israel invested in recently?

Its most recent investments on record: Galecto (Series C, Oct 2018), 89Bio (Series A, Oct 2018) and ChemomAb (Undisclosed round, Dec 2017).

How big are OrbiMed Israel's cheques?

The median round it joins is $46M.

Is OrbiMed Israel investing now?

No investments in the last 12 months; the latest was in Oct 2018.

Who does OrbiMed Israel invest alongside?

Most often OrbiMed (2 rounds together).

What kind of investor is OrbiMed Israel?

OrbiMed Israel is a private equity firm.

Has OrbiMed Israel raised a new fund?

Its latest fund filing with the SEC was in Dec 2015.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it